What is the target price for design Therapeutics (DSGN) stock?

6 brokers have issued 12 month target prices for Design Therapeutics' stock. Their DSGN share price targets range from $6.00 to $7.00. On average, they predict the company's stock price to reach $6.20 in the next year. This suggests a possible upside of 183.1% from the stock's current price.

What is the average TherapeuticsMD stock forecast?

The average TherapeuticsMD stock forecast represents a 13.64% increase from the last price of $4.40000009536743. From AI system, total return is 2366.52% from 4098 forecasts.

Which ETF has the largest weight of design Therapeutics stock?

ETFs with the largest weight of Design Therapeutics (NASDAQ:DSGN) stock in their portfolio include Virtus LifeSci Biotech Clinical Trials ETF (BBC). iShares Neuroscience and Healthcare ETF (IBRN). When did Design Therapeutics IPO? (DSGN) raised $228 million in an initial public offering on Friday, March 26th 2021.